Return to homepagePandemic Pact

National genomic SARS-CoV-2 surveillance programme

  • Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
  • Total publications:0 publications

Grant number: 0142004449

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2022

  • Known Financial Commitments (USD)

    $16,300,628.01

  • Funder

    State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)

  • Principal Investigator

    Abteilung Übertragbare Krankheiten Sekretariat der

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

During the Covid-19 pandemic, it was necessary to closely monitor the development and spread of circulating SARS-CoV-2 variants. Virus variants could influence the epidemiological situation, for example by being more contagious, causing more severe disease, evading immunity after infection or vaccination, or affecting the effectiveness of therapies. This subsidy enabled geographically and demographically representative genome sequencing of 2000 samples per week. This project was coordinated by the National Reference Center for Emerging Viral Infections (NAVI/CRIVE) at HUG. This monitoring made it possible to better assess the development of the pandemic and also served as a basis for decisions for targeted adaptation of measures.